Shareholding disclosure

MindMaze Therapeutics Holding SA

Declared position

36.975%

Threshold

Crossed downwards

Timeline

Published

04.02.2026

Transaction

02.02.2026

Voting rights breakdown

Voting rights acquired4.087%
Voting rights sold36.975%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

ZA01-000000000RLY2

Beneficial owner

MindMaze Therapeutics Holding SA

Declared address

MindMaze Therapeutics Holding SA, Genève, CH

Crossing up of a sale threshold following the recalculation of positions related to equity derivative with actual delivery pursuant to Art. 14 FMIO-FINMA and Art. 4 of Disclosure Office Notice II/13.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open